https://www.selleckchem.com/pr....oducts/obeticholic-a
liver abnormalities are common in COVID-19 patients and associated with higher morbidity and mortality. We aimed to investigate clinical significance and effect on the mortality of abnormal liver function tests (ALFTs) in COVID-19 patients. we retrospectively evaluated in a multicentre study all patients admitted with confirmed diagnosis of COVID-19. 434 patients were included in this analysis. Among overall patients, 311 (71.6%) had normal baseline ALT levels. 123 patients showed overall abnormal liver function tests (ALFTs) a
Like
Comment
Share
